Objectives To develop a regional model of COVID-19 dynamics for use in estimating the number of infections, deaths and required acute and intensive care (IC) beds using the South West England (SW) as an example case. Design Open-source age-structured variant of a susceptible-exposed-infectious-recovered compartmental mathematical model. Latin hypercube sampling and maximum likelihood estimation were used to calibrate to cumulative cases and cumulative deaths. Setting SW at a time considered early in the pandemic, where National Health Service authorities required evidence to guide localised planning and support decision-making. Participants Publicly available data on patients with COVID-19. Primary and secondary outcome measures The expected numbers of infected cases, deaths due to COVID-19 infection, patient occupancy of acute and IC beds and the reproduction (‘R’) number over time. Results SW model projections indicate that, as of 11 May 2020 (when ‘lockdown’ measures were eased), 5793 (95% credible interval (CrI) 2003 to 12 051) individuals were still infectious (0.10% of the total SW population, 95% CrI 0.04% to 0.22%), and a total of 189 048 (95% CrI 141 580 to 277 955) had been infected with the virus (either asymptomatically or symptomatically), but recovered, which is 3.4% (95% CrI 2.5% to 5.0%) of the SW population. The total number of patients in acute and IC beds in the SW on 11 May 2020 was predicted to be 701 (95% CrI 169 to 1543) and 110 (95% CrI 8 to 464), respectively. The R value in SW was predicted to be 2.6 (95% CrI 2.0 to 3.2) prior to any interventions, with social distancing reducing this to 2.3 (95% CrI 1.8 to 2.9) and lockdown/school closures further reducing the R value to 0.6 (95% CrI 0.5 to 0.7). Conclusions The developed model has proved a valuable asset for regional healthcare services. The model will be used further in the SW as the pandemic evolves, and—as open-source software—is portable to healthcare systems in other geographies.
Despite the many examples where simulation has successfully demonstrated its capability in modelling patient flow, there is little evidence of enduring widespread use. Bespoke academic projects provide little scope for repeatable practical application and efforts to develop generic reusable solutions have neither clearly identified the end users nor fully appreciated their multifaceted requirements. Influenced by a review of existing findings and recommendations in addition to a customised survey of prospective end users, a set of practical design principles were elicited in guiding development of a new open-source and versatile tool. Capturing variability in arrivals and length of stay as well as the stochastic nature of dynamic delays in patient discharge and transfer, the PathSimR tool can be used to model various user-defined configurations of outpatient and inpatient pathways. In addition to reporting on early use and engagement initiatives to promote the tool, this study also offers a blueprint for how simulation models can be developed and deployed within the healthcare setting.
6 June 2014 in Journal of The Royal Society Interface
In a novel approach, the standard birth–death process is extended to incorporate a fundamental mechanism undergone by intracellular bacteria, phagocytosis. The model accounts for stochastic interaction between bacteria and cells of the immune system and heterogeneity in susceptibility to infection of individual hosts within a population. Model output is the dose–response relation and the dose-dependent distribution of time until response, where response is the onset of symptoms. The model is thereafter parametrized with respect to the highly virulent Schu S4 strain ofFrancisella tularensis, in the first such study to consider a biologically plausible mathematical model for early human infection with this bacterium. Results indicate a median infectious dose of about 23 organisms, which is higher than previously thought, and an average incubation period of between 3 and 7 days depending on dose. The distribution of incubation periods is right-skewed up to about 100 organisms and symmetric for larger doses. Moreover, there are some interesting parallels to the hypotheses of some of the classical dose–response models, such as independent action (single-hit model) and individual effective dose (probit model). The findings of this study support experimental evidence and postulations from other investigations that response is, in fact, influenced by both in-host and between-host variability.
1 April 2013 in European Journal of Operational Research